Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil
Bochum, North Rhine-Westphalia, 44789, Germany
NCT Number: NCT03900078
This study is aimed to examine the value of incisional negative pressure therapy after resection of soft tissue tumors. Its a prospective randomized trial comparing incisional negative pressure to standard wound dressings.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bochum, North Rhine-Westphalia, 44789, Germany
Wound healing after resection of large soft tissue tumors is often impaired by large dead space and fluid collection, potentially resulting in seroma formation and infection. Aim of the study is to compare negative pressure wound therapy to standard wound dressing in terms of quantity of drainage fluid and wound healing complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A negative pressure dressing is applied to the skin incision.
Regular adhesive wound tapes are applied over the closed skin.
Time frame: up to 14 days postoperatively
Measurement of total fluid amounts in drains and negative pressure device
Time frame: 3 months
Assessment of course of wound healing, necessary operative revisions, seroma formation
Time frame: 5 days postoperatively
Measurement with laser doppler
Ruhr University of Bochum
Other
Inzisionelle Negative Drucktherapie Nach Resektion Von Weichteiltumoren - Eine Prospektive, Randomisierte, Kontrollierte Klinische Studie
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00898755
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Birmingham, Alabama, United States
View Trial DetailsNCT02632448
Adnexal Diseases, Breast Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT03997968
Adnexal Diseases, Blood Protein Disorders
San Francisco, California, United States
View Trial DetailsNCT06202599
Bone Diseases, Bone Neoplasms
Beijing, Beijing Municipality, China
View Trial Details